![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0acaf27b0a4de4c33_resources-hero_cell1.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809af6100c642491b1144_resources-hero_cell2.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c9a071f3e1315c44_resources-hero_cell3.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809aff7e7c55068ea25b5_resources-hero_cell4.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c077d95e001f56d8_resources-hero_cell5.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0a95ec247802ff9ad_resources-hero_cell6.webp)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 1, 2009
Source Plasma Donors and Donation
The Facts about Source Plasma Donors.
All
Fact sheets
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64529e2cea2349db307453d3_FS_Source_Plasma_Donors.pdf
May 1, 2009
Source Plasma Donors and Donation
The Facts about Source Plasma Donors.
All
Fact sheets
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64529e2cea2349db307453d3_FS_Source_Plasma_Donors.pdf
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
Jun 1, 2007
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
PPTA members are committed to providing safe and effective therapies and PPTA understands that patients who rely on plasma protein therapies may have concerns about the possible transmission of highly virulent strains of influenza H5N1 viruses through these therapies. Therefore, PPTA members continue to work to ensure that these viruses or any other emerging disease, do not compromise the safety of plasma protein therapies.
All
PPTA statements
Jun 1, 2007
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
PPTA members are committed to providing safe and effective therapies and PPTA understands that patients who rely on plasma protein therapies may have concerns about the possible transmission of highly virulent strains of influenza H5N1 viruses through these therapies. Therefore, PPTA members continue to work to ensure that these viruses or any other emerging disease, do not compromise the safety of plasma protein therapies.
All
PPTA statements
Jul 21, 2005
Statement on Update on Safety of Albumin
The Plasma Protein Therapeutics Association (PPTA) appreciates actions taken by the FDA and the Blood Products Advisory Committee (BPAC) with respect to the safety of albumin.
All
PPTA statements
Jul 21, 2005
Statement on Update on Safety of Albumin
The Plasma Protein Therapeutics Association (PPTA) appreciates actions taken by the FDA and the Blood Products Advisory Committee (BPAC) with respect to the safety of albumin.
All
PPTA statements
No results found